GlassScriptPhysician profile
Samrina Hanif
NPI 1992852719
$11,993.23
in general payments reported to CMS, 2019-2025
28 companies · $1,781 in 2025
The $1,781 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,223 · 2020: $174 · 2021: $274 · 2022: $2,145 · 2023: $4,450 · 2024: $947 · 2025: $1,781.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,016 · Food and Beverage: $3,116 · Education: $45.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,016.00 |
| Food and Beverage | $3,115.53 |
| Education | $45.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $6,450.74 | 2019-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Medtronic USA, INC. | $2,052.96 | 2019-2020 | |
| Abbvie INC. | $1,202.95 | 2024-2025 | |
| Neurelis, INC. | $551.73 | 2021-2025 | Valtoco |
| Ucb, INC. | $417.31 | 2020-2025 | Briviact |
| Sk Life Science, INC. | $167.81 | 2020-2025 | |
| Medtronic, INC. | $125.95 | 2021-2025 | Percept PC Brainsense |
| Biogen, INC. | $114.28 | 2019-2025 | Tysabri, Vumerity |
| Acadia Pharmaceuticals INC | $105.15 | 2024-2025 | Nuplazid, Daybue |
| Neurocrine Biosciences, INC. | $104.74 | 2024-2025 | Ingrezza |
| Merz Pharmaceuticals, LLC | $101.88 | 2025 | Xeomin, Ampyra, Inbrija |
| Sunovion Pharmaceuticals INC. | $71.33 | 2021 | |
| Pfizer INC. | $66.75 | 2024-2025 | |
| Lundbeck LLC | $65.61 | 2023-2025 | Vyepti |
| Amgen INC. | $60.16 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Catalyst Pharmaceuticals, INC. | $47.06 | 2024 | |
| Lilly USA, LLC | $38.11 | 2019-2024 | Zepbound, Jardiance |
| Kyowa Kirin, INC. | $30.40 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $30.00 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $26.17 | 2025 | |
| Argenx US, INC. | $26.16 | 2024 | Vyvgart Hytrulo |
| Emd Serono, INC. | $24.87 | 2025 | |
| Aquestive Therapeutics, INC. | $23.97 | 2021 | |
| Xeris Pharmaceuticals, INC. | $23.88 | 2024 | Keveyis |
| Mallinckrodt Hospital Products INC. | $23.54 | 2025 | Acthar |
| Genzyme Corporation | $14.74 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.66 | 2022 | |
| Sumitomo Pharma America, INC. | $12.32 | 2023 | Aptiom |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samrina Hanif listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.